The North America general anesthesia drugs market dominated the overall market with a share of 36.05% in 2024. • The general anesthesia drugs market in the Asia Pacific region is expanding rapidly at ...

Deprescribing medications known as ‘fall-risk increasing drugs’ (FRIDs) is a common strategy to prevent falls. We conducted a systematic review to determine its efficacy for the prevention of falls ...

Propofol and IV Anesthesia Lead the Way as Global Anesthesia Drugs market Expected to Grow at a CAGR of 4.2% by 2032 AUSTIN, TX, UNITED STATES, January 29, 2025 /EINPresswire / -- According to ...

The waiver, announced by Secretary of State Marco Rubio, seemed to allow for the distribution of H.I.V. medications, but whether the waiver extended to preventive drugs or other services offered ...

With GLP-1-related drugs having won the race to weight loss ... the trickier task of finding a way to lose fat while retaining muscle. Veru is one biotech that thinks it’s found an answer.

Veru declined over 40% to Patients on Veru's oral drug, enobosarm, and Wegovy lost 71% less lean muscle on average than those who received placebo and Wegovy over 16 weeks. Those who received the ...

That included an addiction to heroin, which Dion first snorted at 14 and finally kicked, along with all other drugs, in 1968: the year of his comeback hit, “Abraham, Martin and John,” a folk ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...

If you're one of the 13% of American adults who has taken a GLP-1 drug for weight loss, you may know that while fat seemingly melts away, so too does muscle. And if you're not one for weights ...

DUBLIN--(BUSINESS WIRE)--The "United States Anesthesia Drugs Market by Type by General Inhalation by General Intravenous by Local, and Company Analysis 2025 to 2033" report has been added to ...

This leads to impaired development of the skeletal muscle fibers. The researchers also investigated the drugs nilotinib and imatinib, which belong to the same class of chemotherapeutic agents.